                         SEQUENCE LISTING

<110>  Oxford University Innovation Limited
 
<120>  Biomarkers

<130>  N408344WO

<150>  GB1614455.2
<151>  2016-08-24

<160>  44    

<170>  PatentIn version 3.5

<210>  1
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  APO-F peptide-1

<400>  1

Ser Leu Pro Thr Glu Asp Cys Glu Asn Glu Lys 
1               5                   10      


<210>  2
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  APO-F peptide-2

<400>  2

Ser Gly Val Gln Gln Leu Ile Gln Tyr Tyr Gln Asp Gln Lys 
1               5                   10                  


<210>  3
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  APO-F peptide-4


<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  may be O-glycosylated threonine

<400>  3

Asp Ala Asn Ile Ser Gln Pro Glu Thr Thr Lys 
1               5                   10      


<210>  4
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  APO-F peptide-3

<400>  4

Ser Tyr Asp Leu Asp Pro Gly Ala Gly Ser Leu Glu Ile 
1               5                   10              


<210>  5
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Tryptic peptide

<400>  5

Leu Leu Glu Asp Gly Glu Asp Phe Asn Leu Gly Asp Ala Leu Asp Ser 
1               5                   10                  15      


Ser Asn Ser Met Gln Thr Ile Gln Lys 
            20                  25  


<210>  6
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cleaved tryptic peptide

<400>  6

Leu Leu Glu Asp Gly Glu Asp Phe Asn Leu Gly Asp Ala Leu Asp 
1               5                   10                  15  


<210>  7
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cleaved tryptic peptide

<400>  7

Ser Ser Asn Ser Met Gln Thr Ile Gln Lys 
1               5                   10  


<210>  8
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  T-kinin

<400>  8

Ile Ser Leu Met Lys Arg Pro Pro Gly Phe Ser Pro Phe Arg 
1               5                   10                  


<210>  9
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  bradykinin


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  maybe Hydroxylated proline

<400>  9

Arg Pro Pro Gly Phe Ser Pro Phe Arg 
1               5                   


<210>  10
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  lysyl-bradykinin

<400>  10

Lys Arg Pro Pro Gly Phe Ser Pro Phe Arg 
1               5                   10  


<210>  11
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycated N terminal peptide from hemoglobin beta chain


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  may be glycated valine

<400>  11

Val His Leu Thr Pro Glu Glu Lys 
1               5               


<210>  12
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  angiotensin-1

<400>  12

Asp Arg Val Tyr Ile His Pro Phe His Leu 
1               5                   10  


<210>  13
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  angiotensin 1-9

<400>  13

Asp Arg Val Tyr Ile His Pro Phe His 
1               5                   


<210>  14
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  angiotensin-2

<400>  14

Asp Arg Val Tyr Ile His Pro Phe 
1               5               


<210>  15
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  angiotensin 1-7

<400>  15

Asp Arg Val Tyr Ile His Pro 
1               5           


<210>  16
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  angiotensin 1-5

<400>  16

Asp Arg Val Tyr Ile 
1               5   


<210>  17
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  angiotensin 1-4

<400>  17

Asp Arg Val Tyr 
1               


<210>  18
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  angiotensin-3

<400>  18

Arg Val Tyr Ile His Pro Phe 
1               5           


<210>  19
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  angiotensin-4

<400>  19

Val Tyr Ile His Pro Phe 
1               5       


<210>  20
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4B sequence 1

<400>  20

Val Asp Gly Ser Val Asp Phe Tyr Arg 
1               5                   


<210>  21
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4B sequence 2

<400>  21

Leu Gly Glu Phe Trp Leu Gly Asn Asp Asn Ile His Ala Leu Thr Ala 
1               5                   10                  15      


Gln Gly Thr Ser Glu Leu Arg 
            20              


<210>  22
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4B sequence 3

<400>  22

Asn Cys His Val Ser Asn Leu Asn Gly Arg 
1               5                   10  


<210>  23
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4C sequence 1

<400>  23

Ile Glu Asp Ala Asn Leu Ile Pro Pro Val Pro Asp Asp Lys 
1               5                   10                  


<210>  24
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4C sequence 2

<400>  24

Gly Phe Leu Leu Leu Ala Ser Leu Arg 
1               5                   


<210>  25
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4C sequence 3

<400>  25

Ala Gly Thr Leu Asp Leu Ser Leu Thr Val Gln Gly Lys 
1               5                   10              


<210>  26
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4D sequence 1

<400>  26

Gly Asp Ile Gly Glu Thr Gly Val Pro Gly Ala Glu Gly Pro Arg 
1               5                   10                  15  


<210>  27
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4D sequence 2

<400>  27

Ile Phe Tyr Asn Gln Gln Asn His Tyr Asp Gly Ser Thr Gly Lys 
1               5                   10                  15  


<210>  28
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4D sequence 3

<400>  28

Asn Gly Leu Tyr Ala Asp Asn Asp Asn Asp Ser Thr Phe Thr Gly Phe 
1               5                   10                  15      


Leu Leu Tyr His Asp Thr Asn 
            20              


<210>  29
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4E sequence 1

<400>  29

Tyr Asp Leu Ala Phe Val Val Ala Ser Gln Ala Thr Lys 
1               5                   10              


<210>  30
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4E sequence 2

<400>  30

Leu Asp Ser Leu Val Ala Gln Gln Leu Gln Ser Lys 
1               5                   10          


<210>  31
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4E sequence 3

<400>  31

Gly Ala Thr Thr Ser Pro Gly Val Tyr Glu Leu Ser Ser Arg 
1               5                   10                  


<210>  32
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4F sequence

<400>  32

Ala Leu Asp Phe Ala Val Gly Glu Tyr Asn Lys 
1               5                   10      


<210>  33
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4G sequence 1

<400>  33

Ser Phe Arg Pro Phe Val Pro Arg 
1               5               


<210>  34
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4G sequence 2

<400>  34

Ile Thr Gly Phe Leu Lys Pro Gly Lys 
1               5                   


<210>  35
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4G sequence 3

<400>  35

Val Gln Leu Tyr Asp Leu Gly Leu Gln Ile His Lys 
1               5                   10          


<210>  36
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4H sequence 1

<400>  36

Glu His Val Ala His Leu Leu Phe Leu Arg 
1               5                   10  


<210>  37
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4H sequence 2

<400>  37

Asn Trp Gly Leu Ser Phe Tyr Ala Asp Lys Pro Glu Thr Thr Lys 
1               5                   10                  15  


<210>  38
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4H sequence 3

<400>  38

Glu Gln Leu Gly Glu Phe Tyr Glu Ala Leu Asp Cys Leu Cys Ile Pro 
1               5                   10                  15      


Arg 
    


<210>  39
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4I sequence 1

<400>  39

Ala Leu Gly His Leu Asp Leu Ser Gly Asn Arg 
1               5                   10      


<210>  40
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4I sequence 2

<400>  40

Val Ala Ala Gly Ala Phe Gln Gly Leu Arg 
1               5                   10  


<210>  41
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4I sequence 3

<400>  41

Gly Gln Thr Leu Leu Ala Val Ala Lys 
1               5                   


<210>  42
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4J  sequence 1

<400>  42

Val Leu Asn Gln Glu Leu Arg 
1               5           


<210>  43
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4J sequence 2

<400>  43

Asn Pro Asn Leu Pro Pro Glu Thr Val Asp Ser Leu Lys 
1               5                   10              


<210>  44
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Figure 4J sequence 3

<400>  44

Asn Ile Leu Thr Ser Asn Asn Ile Asp Val Lys 
1               5                   10      


